Skip to content
  • Topics
    • Obesity/Cancer FAQs
    • General News
    • Gastroparesis
    • Learn about Lipids
      • Obese vs Non-Obese
    • Obesity Drugs
      • Semaglutide
      • Tirzepatide
      • Obesity Drugs in the Pipeline
    • Lawsuits
    • Bariatric Surgery
    • Grants
    • Addiction
    • Journals/References/Books
    • Clinical Trials
      • Clinical Trials – United States
      • Clincal Trials – ExUS
      • Breast Cancer-Obesity Clinical Trials
    • FDA
    • Conferences
      • Conference Updates
    • Institutions
  • Blog Posts / News
    • Login
    • News Archive
    • Posts Archive
    • Guest Post
    • Author’s Registration Page
    • Author’s Post Page
    • Bloggers
  • Related Cancers
    • Breast
    • Colon & Rectum
    • Kidney
    • Endometrium
    • Pancreas
    • Thyroid
    • Liver
    • Multiple Myeloma
    • Upper Stomach
    • Meningioma
    • Adenocarcinoma of the Esophagus
    • Ovary
    • Gallbladder
    • Pediatric
    • Mesothelioma
  • About
  • Contact
  • Topics
    • Obesity/Cancer FAQs
    • General News
    • Gastroparesis
    • Learn about Lipids
      • Obese vs Non-Obese
    • Obesity Drugs
      • Semaglutide
      • Tirzepatide
      • Obesity Drugs in the Pipeline
    • Lawsuits
    • Bariatric Surgery
    • Grants
    • Addiction
    • Journals/References/Books
    • Clinical Trials
      • Clinical Trials – United States
      • Clincal Trials – ExUS
      • Breast Cancer-Obesity Clinical Trials
    • FDA
    • Conferences
      • Conference Updates
    • Institutions
  • Blog Posts / News
    • Login
    • News Archive
    • Posts Archive
    • Guest Post
    • Author’s Registration Page
    • Author’s Post Page
    • Bloggers
  • Related Cancers
    • Breast
    • Colon & Rectum
    • Kidney
    • Endometrium
    • Pancreas
    • Thyroid
    • Liver
    • Multiple Myeloma
    • Upper Stomach
    • Meningioma
    • Adenocarcinoma of the Esophagus
    • Ovary
    • Gallbladder
    • Pediatric
    • Mesothelioma
  • About
  • Contact

Archives

A type of fibre that stimulates GLP-1 release approved for use in food

Thursday, July 2 – A form of fibre that boosts the release of the hunger-reducing hormone GLP-1 has been approved as safe by a European regulator, and could be added to foods within a year

STAT+: More signs that GLP-1s may help with peripheral artery disease

Thursday, July 2 – Anthropic will begin developing drugs, BridgeBio pockets a billion, and more biotech news from The Readout

Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know

Thursday, July 2 – The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans

Semaglutide for Weight Loss Without Diabetes: What the Approval Covers, What Programs Skip, and What Results Actually Look Like

Tuesday, May 19 – Semaglutide for Weight Loss Without Diabetes: What the Approval Covers, What Programs Skip, and What Results Actually Look Like

← Previous
© Copyright 2026 GenWeb of Texas